Serratia marcescens endocarditis. A review of the literature and report of a case involving a homograft replacement of the aortic valve.
D001021:Aortic Valve / Q000637:transplantation*; D002512:Cephalothin / Q000627:therapeutic use; D002701:Chloramphenicol / Q000627:therapeutic use; D002751:Chlortetracycline / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D004697:Endocarditis, Bacterial / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy; D005112:Extracorporeal Circulation; D006350:Heart Valve Prosthesis; D006801:Humans; D007612:Kanamycin / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009355:Neomycin / Q000627:therapeutic use; D011183:Postoperative Complications / Q000209:etiology*; D018805:Sepsis / Q000209:etiology; D012706:Serratia marcescens; D013307:Streptomycin / Q000627:therapeutic use; D013411:Sulfadiazine / Q000627:therapeutic use; D014184:Transplantation, Homologous
D013411:Sulfadiazine; D007612:Kanamycin; D002701:Chloramphenicol; D009355:Neomycin; D002512:Cephalothin; D002751:Chlortetracycline; D013307:Streptomycin